We are live on ! Find out more
Vanguard Global Advisers

Vanguard Global Advisers Portfolio holdings

AUM $215B
This Fund
S&P 500
This Quarter Est. Return
+22.32%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$215B
AUM Growth
+$28.1B
Cap. Flow
+$1.96B
Cap. Flow %
0.91%
Top 10 Hldgs %
41.33%
Holding
3,754
New
71
Increased
744
Reduced
1,650
Closed
116

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$189M
2
HON icon
Honeywell
HON
+$157M
3
AAPL icon
Apple
AAPL
+$124M
4
MSFT icon
Microsoft
MSFT
+$89M
5
AMZN icon
Amazon
AMZN
+$62.1M

Sector Composition

Rank Sector Weight
1 Technology 25.83%
2 Financials 11.43%
3 Communication Services 6.64%
4 Consumer Discretionary 6.57%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPAY icon
1526
Repay Holdings
RPAY
$318M
$1.4M ﹤0.01%
333,250
+49,548
+17% +$172K
CALM icon
1527
Cal-Maine
CALM
$3.77B
$1.4M ﹤0.01%
17,352
-559
-3% -$43.2K
FG icon
1528
F&G Annuities & Life
FG
$3.49B
$1.4M ﹤0.01%
52,514
+5,472
+12% +$150K
AXGN icon
1529
Axogen
AXGN
$2.61B
$1.39M ﹤0.01%
30,113
+4,555
+18% +$184K
WTTR icon
1530
Select Water Solutions
WTTR
$2.71B
$1.39M ﹤0.01%
69,609
+22,595
+48% +$396K
AMRX icon
1531
Amneal Pharmaceuticals
AMRX
$6.33B
$1.39M ﹤0.01%
80,334
-26,220
-25% -$359K
GBX icon
1532
The Greenbrier Companies
GBX
$1.42B
$1.39M ﹤0.01%
28,285
-708
-2% -$34.8K
AVNT icon
1533
Avient
AVNT
$4.16B
$1.38M ﹤0.01%
37,453
-1,080
-3% -$39.1K
CPRX
1534
DELISTED
Catalyst Pharmaceutical
CPRX
$1.38M ﹤0.01%
44,028
-1,827
-4% -$53.9K
IBRX icon
1535
ImmunityBio
IBRX
$8.28B
$1.38M ﹤0.01%
157,793
+9,073
+6% +$68.7K
DAN icon
1536
Dana Inc
DAN
$3.38B
$1.38M ﹤0.01%
50,687
-8,150
-14% -$278K
BHF icon
1537
Brighthouse Financial
BHF
$3.27B
$1.38M ﹤0.01%
21,774
-1,429
-6% -$88.9K
OGN icon
1538
Organon & Co
OGN
$3.6B
$1.38M ﹤0.01%
101,713
-179,401
-64% -$2.15M
CBU icon
1539
Community Bank
CBU
$3.44B
$1.37M ﹤0.01%
20,462
-635
-3% -$40.2K
ADPT icon
1540
Adaptive Biotechnologies
ADPT
$4.02B
$1.37M ﹤0.01%
63,932
-240
-0.4% -$3.68K
AMBA icon
1541
Ambarella
AMBA
$3.45B
$1.37M ﹤0.01%
15,968
-768
-5% -$52.9K
HRTG icon
1542
Heritage Insurance Holdings
HRTG
$1.01B
$1.37M ﹤0.01%
52,483
+13,610
+35% +$339K
UVV icon
1543
Universal Corp
UVV
$1.09B
$1.37M ﹤0.01%
26,224
-12,932
-33% -$689K
EEFT icon
1544
Euronet Worldwide
EEFT
$2.64B
$1.37M ﹤0.01%
18,678
-8,053
-30% -$562K
MSGE icon
1545
Madison Square Garden
MSGE
$4.01B
$1.37M ﹤0.01%
16,897
+319
+2% +$21.8K
CAKE icon
1546
Cheesecake Factory
CAKE
$5.47B
$1.36M ﹤0.01%
17,129
-1,573
-8% -$102K
ELVN icon
1547
Enliven Therapeutics
ELVN
$4.26B
$1.36M ﹤0.01%
26,833
+9,082
+51% +$386K
UTZ icon
1548
Utz Brands
UTZ
$1.25B
$1.36M ﹤0.01%
176,531
+107,754
+157% +$804K
SMP icon
1549
Standard Motor Products
SMP
$872M
$1.36M ﹤0.01%
34,875
-4,055
-10% -$155K
CMRE icon
1550
Costamare
CMRE
$1.82B
$1.36M ﹤0.01%
96,922
+2,976
+3% +$48.8K

Similar funds

Vanguard Global Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, Vanguard Global Advisers held 3,754 positions worth $215B, up 15% from $187B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 5%. Vanguard Global Advisers opened 71 new positions and exited 116, leaving the 3,754-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Communication Services.

  • Vanguard Global Advisers's largest Q2 2026 buy was Honeywell Aerospace: 682,434 shares worth $151M.
  • Vanguard Global Advisers added most to Vanguard S&P 500 ETF in Q2 2026, an estimated $1.11B increase.
  • Vanguard Global Advisers's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $189M.
  • Vanguard Global Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $58.2M.
  • Vanguard Global Advisers's ten largest holdings make up 41% of its $215B portfolio in Q2 2026.
  • Vanguard Global Advisers opened 71 new positions and closed 116 in Q2 2026.
  • Vanguard Global Advisers's portfolio value rose 15% quarter-over-quarter to $215B.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.